comparemela.com

Latest Breaking News On - Merck sharp dohme ltd - Page 1 : comparemela.com

Intech testing new asthma inhaler with eye on US market

Intech Biopharm Corp (益得生技) has started testing the effects of a metered-dose inhaler generic of Teva Pharmaceutical Industries Ltd’s ProAir, and expects to gain marketing approval by 2023, it said yesterday. The company, which developed SYN011 to treat acute asthma, received approval from the US Food and Drug Administration in August to study the biochemical and physiological effects of the drug in a phase 3 clinical trial, Intech spokesperson Hugues Hung (洪堯國) told the Taipei Times. The company has recruited about 200 participants with asthma for the test, dividing them into control and experiment groups to receive a placebo, a brand name

GSK withdraws HIBERIX in Vietnam due to low demand

GSK withdraws HIBERIX in Vietnam due to low demand 16:41 | 15/12/2020 HIBERIX produced by GlaxoSmithKline A representative of GSK Vietnam told VIR that this is the vaccine for prevention of diseases caused by Haemophilus Influenzae type b bacteria for children, which have been already part of the current 5-in-1 vaccine provided to eligible children in the Expanded Program on Immunization (EPI) of the government for many years and there were other alternative vaccines available in Vietnam to serve medical needs. “GSK has filed the application to discontinue this vaccine in Vietnam and got approval from the Drug Administration of Vietnam for discontinuation in November 2020,” she added.

Popular pharma products withdrawn by multinationals

Popular pharma products withdrawn by multinationals 10:00 | 10/12/2020 Popular pharma products withdrawn by multinationals, illustration photo According to the Drug Administration of Vietnam (DAV) under the Ministry of Health, as many as 20 pharmaceuticals of multinational corporations (MNCs) have requested and been granted revocation of marketing authorisation from registration units. Many pharma companies often request a withdrawal in order to rename or repackage particular products, although it is not known what percentage of companies do so for other reasons. In the DAV’s Decision No.597/QD-QLD dated November 27 on the withdrawal, Lactacyd FH manufactured and registered by Sanofi-Synthelabo Vietnam is among the names.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.